Last reviewed · How we verify

NCT03767803

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Status unknown Last updated 23 January 2020
What this trial tests

trial testing Non-interventional study in Pre-Eclampsia in 344 participants. Status unknown.

Timeline
1 October 2018
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorProgenity, Inc.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment344
Start date1 October 2018
Primary completion31 December 2020
Estimated completion31 December 2020
Sites24 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Progenity, Inc.

Who can join

Adults 18 to 45, female only, with Pre-Eclampsia or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Whole blood sample procurement study from pregnant women with signs and symptoms of Preeclampsia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non-interventional study

Trials testing the same drug.

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing